biote (NASDAQ:BTMD – Get Free Report) will be posting its quarterly earnings results after the market closes on Tuesday, November 12th. Analysts expect biote to post earnings of $0.09 per share for the quarter. Investors that wish to register for the company’s conference call can do so using this link.
biote (NASDAQ:BTMD – Get Free Report) last released its earnings results on Thursday, August 8th. The company reported $0.14 EPS for the quarter, topping analysts’ consensus estimates of $0.09 by $0.05. The company had revenue of $49.17 million for the quarter, compared to analysts’ expectations of $50.40 million. biote had a negative return on equity of 20.92% and a net margin of 3.67%. On average, analysts expect biote to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.
biote Stock Performance
BTMD opened at $5.56 on Monday. biote has a fifty-two week low of $3.65 and a fifty-two week high of $8.44. The firm has a 50-day moving average of $5.53 and a 200 day moving average of $6.27. The firm has a market cap of $301.46 million, a P/E ratio of 32.71 and a beta of 0.94.
About biote
biote Corp. operates in practice-building business within the hormone optimization space. It trains physicians and nurse practitioners in hormone optimization using bioidentical hormone replacement pellet therapy in men and women experiencing hormonal imbalance. The company offers Biote Method, a comprehensive end-to-end practice building platform that provides Biote-certified practitioners with the components developed for practitioners in the hormone optimization space comprising Biote Method education, training, and certification services; practice management software that allows Biote-certified practitioners to order, track, and manage hormone optimization product inventory and other administrative requirements; inventory management software to monitor pellet inventory; and information regarding available hormone replacement therapy products, as well as digital and point-of-care marketing support.
Featured Stories
- Five stocks we like better than biote
- Dividend Capture Strategy: What You Need to Know
- California Resources Stock Could Be a Huge Long-Term Winner
- The Basics of Support and Resistance
- Observability Wars: Datadog and Dynatrace Vie for Data Dominance
- Best Stocks Under $5.00
- Airbnb Stock Attracts Attention With Strong Cash Flow Strategy
Receive News & Ratings for biote Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for biote and related companies with MarketBeat.com's FREE daily email newsletter.
